CPS Technologies Corp. (NASDAQ:CPSH) has secured a $1.15 million Phase II Small Business Technology Transfer (STTR) contract from the U.S. Army Combat Capabilities Development Command (DEVCOM) to advance development of controlled fragmentation tungsten warheads. The two-year contract, announced September 22, 2025, builds on successful Phase I results and represents the company's fifth new federally funded project of 2025.
Innovative Manufacturing Approach
The project centers on CPS Technologies' proprietary injection molding process, which enables production of highly detailed tungsten features for warhead applications. This manufacturing approach offers a cost-effective alternative to traditional labor-intensive machining while providing improved precision in warhead design and functionality. The initial development focus targets a 40mm warhead variant.
Dr. Mark Occhionero, PhD, will continue serving as principal investigator for the project. According to Brian Mackey, President & CEO of CPS Technologies, "The initial Phase I effort delivered very promising results under Dr. Occhionero's guidance. With this contract, the prototypes we develop will undergo rigorous testing to meet the Army's demanding performance standards."
Strategic Partnership and Expertise
The New Mexico Institute of Mining and Technology's Energetic Materials Research and Testing Center (EMRTC) will partner with CPS as a subcontractor during Phase II. EMRTC is described as an internationally recognized research and training center committed to artillery research and testing.
Mackey emphasized the significance of Dr. Occhionero's contributions, noting his "nearly 40-year tenure with CPS is a testament to his deep expertise. Among his many contributions, he has been instrumental in guiding the continued development of our injection molding process, which over the years has resulted in literally millions of successful product shipments."
Company Growth and Technology Applications
This contract marks CPS Technologies' third successful conversion of a Phase I program to Phase II since June 2024, demonstrating the company's ability to advance defense-related research initiatives. The company specializes in high-performance material solutions across diverse applications, including electric vehicles, Navy ships, aerospace applications, and ballistic protection systems.
CPS's injection molding technology has proven versatile, with applications spanning from clean energy solutions to defense requirements. The company's armor products provide ballistic protection and environmental durability at reduced weight, while their hermetic packages serve aerospace and satellite applications.
